BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37537884)

  • 21. Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis.
    Lee JS; Hong GY; Lee KH; Song JH; Kim TE
    Ultrasound Med Biol; 2019 Dec; 45(12):3214-3221. PubMed ID: 31563479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relugolix for the treatment of uterine fibroids.
    Rocca ML; Palumbo AR; Lico D; Fiorenza A; Bitonti G; D'Agostino S; Gallo C; Di Carlo C; Zullo F; Venturella R
    Expert Opin Pharmacother; 2020 Oct; 21(14):1667-1674. PubMed ID: 32674616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
    Magalhaes J; Ferreira-Filho ES; Soares-Junior JM; Baracat EC
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():56-62. PubMed ID: 35809459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Feasibility and safety of MRgFUS ablation for uterine fibroids and adenomyosis: a preliminary study].
    Huang YQ; Zhou SG; Wang J; Deng LX; Li ZW; Xu YH
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1152-1155. PubMed ID: 31006218
    [No Abstract]   [Full Text] [Related]  

  • 26. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials.
    Venturella R; Rechberger T; Zatik J; Wagman RB; Zhu E; Rakov VG; Petraglia F
    Gynecol Endocrinol; 2023 Aug; 39(1):2249107. PubMed ID: 37634528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
    Osuga Y; Enya K; Kudou K; Hoshiai H
    Fertil Steril; 2019 Nov; 112(5):922-929.e2. PubMed ID: 31594635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal adenomyosis (intramural endometriotic cyst) in a very young patient - differential diagnosis with uterine fibromatosis.
    Manta L; Suciu N; Constantin A; Toader O; Popa F
    J Med Life; 2016; 9(2):180-2. PubMed ID: 27453751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.
    Taran FA; Weaver AL; Coddington CC; Stewart EA
    Hum Reprod; 2010 May; 25(5):1177-82. PubMed ID: 20176591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas.
    Lonky NM; Chiu V; Portugal C; Estrada EL; Chang J; Fischer H; Vora JB; Harrison LI; Peng L; Munro MG
    PLoS One; 2023; 18(12):e0294925. PubMed ID: 38079406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
    Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
    Kawahara N; Kawaguchi R; Yamamoto K; Nishikawa K; Matsuoka M; Maehana T; Fukui Y; Yamanaka S; Sugimoto S; Iwai K; Yamada Y; Kurakami H; Hirata T; Takashima R; Suzuki S; Asada K; Kasahara M; Kimura F
    Trials; 2024 Jan; 25(1):68. PubMed ID: 38243317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term medical management of uterine fibroids with ulipristal acetate.
    Donnez J; Donnez O; Matule D; Ahrendt HJ; Hudecek R; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Loumaye E
    Fertil Steril; 2016 Jan; 105(1):165-173.e4. PubMed ID: 26477496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging.
    Siskin GP; Tublin ME; Stainken BF; Dowling K; Dolen EG
    AJR Am J Roentgenol; 2001 Aug; 177(2):297-302. PubMed ID: 11461849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
    Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
    J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of endometriosis among patients with adenomyosis and/or myoma uteri scheduled for a hysterectomy.
    Naphatthalung W; Cheewadhanaraks S
    J Med Assoc Thai; 2012 Sep; 95(9):1136-40. PubMed ID: 23140029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of soluble HLA-G serum levels in patients with adenomyosis and uterine fibroids before and after surgery.
    Xie Y; Gao Y; Liu W; Zou Y; Li C
    Hum Immunol; 2023 Aug; 84(8):418-422. PubMed ID: 37059598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.